Katsuhito Ihara

8PUBLICATIONS
53CO-AUTHORS
Major global burdens of diseaseMedical biochemistry - proteins and peptides (incl. medical proteomics)Molecular targetsPredictive and prognostic markersRehabilitation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 03, 2025
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

|Oct 31, 2024
Classification of Predictors of Rapid Development of Kidney Failure and Short-Term Changes in Concentration of Circulating Proteins.

Hiroki Kobayashi, Helen C Looker, Katsuhito Ihara

|Aug 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.

Hiroki Kobayashi, Helen C Looker, Eiichiro Satake

|Jan 03, 2021
Minimal change disease concurrent with acute interstitial nephritis after long-term use of sorafenib in a patient with renal cell carcinoma.

Katsuhito Ihara, Tatemitsu Rai, Hidenori Nishida

|Sep 05, 2020
Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria.

Katsuhito Ihara, Jan Skupien, Hiroki Kobayashi

|Feb 20, 2019
Predictors of withdrawal from renal replacement therapy among patients with acute kidney injury requiring renal replacement therapy.

Katsuhito Ihara, Junichi Ishigami, Seiji Inoshita

Pageof 2

Frequent Collaborators

4 joint publications

Eiichiro Satake

4 joint publications

Andrzej S Krolewski

3 joint publications

Robert G Nelson

3 joint publications

Hiroki Kobayashi